We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
-14.37%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.55%
10 Year Est. Return
+237.03%
AUM
$4.54B
AUM Growth
+$253M
Cap. Flow
+$1.18B
Cap. Flow %
25.96%
Top 10 Hldgs %
33.8%
Holding
1,175
New
218
Increased
613
Reduced
164
Closed
126

Sector Composition

Rank Sector Weight
1 Technology 11.33%
2 Consumer Discretionary 7.6%
3 Consumer Staples 5.46%
4 Financials 5.09%
5 Healthcare 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIVB
301
DELISTED
SVB Financial Group
SIVB
$1.22M 0.03%
3,100
+164
+6% +$77.3K
VONG icon
302
Vanguard Russell 1000 Growth ETF
VONG
$44.7B
$1.22M 0.03%
21,730
+18,445
+561% +$1.14M
WAB icon
303
Wabtec
WAB
$49.9B
$1.22M 0.03%
14,891
+430
+3% +$38.3K
LHCG
304
DELISTED
LHC Group LLC
LHCG
$1.22M 0.03%
7,828
+2,014
+35% +$332K
JSTC icon
305
Adasina Social Justice All Cap Global ETF
JSTC
$301M
$1.21M 0.03%
84,451
TWTR
306
DELISTED
Twitter, Inc.
TWTR
$1.2M 0.03%
32,121
+17,615
+121% +$756K
AMGN icon
307
Amgen
AMGN
$219B
$1.2M 0.03%
4,927
+3,279
+199% +$804K
LECO icon
308
Lincoln Electric
LECO
$15.2B
$1.18M 0.03%
9,563
+24
+0.3% +$3.16K
FTNT icon
309
Fortinet
FTNT
$117B
$1.18M 0.03%
20,852
-6,768
-25% -$402K
CEMB icon
310
iShares JPMorgan EM Corporate Bond ETF
CEMB
$405M
$1.17M 0.03%
+27,343
New +$1.22M
FISV
311
Fiserv Inc
FISV
$28.9B
$1.16M 0.03%
13,041
+4,744
+57% +$460K
AMP icon
312
Ameriprise Financial
AMP
$49.5B
$1.16M 0.03%
4,877
+307
+7% +$82.2K
AVEM icon
313
Avantis Emerging Markets Equity ETF
AVEM
$26.1B
$1.15M 0.03%
+22,158
New +$1.23M
APH icon
314
Amphenol
APH
$210B
$1.13M 0.02%
35,006
-2,286
-6% -$79.5K
UBS icon
315
UBS Group
UBS
$173B
$1.13M 0.02%
70,075
+3,350
+5% +$58.7K
APD icon
316
Air Products & Chemicals
APD
$66.8B
$1.12M 0.02%
4,666
+1,371
+42% +$333K
PKG icon
317
Packaging Corp of America
PKG
$22.5B
$1.12M 0.02%
8,099
+748
+10% +$116K
GSK icon
318
GSK
GSK
$104B
$1.11M 0.02%
20,290
+14,329
+240% +$791K
DGRO icon
319
iShares Core Dividend Growth ETF
DGRO
$43.4B
$1.1M 0.02%
23,145
+7,065
+44% +$356K
IFF icon
320
International Flavors & Fragrances
IFF
$21.6B
$1.1M 0.02%
9,212
+1,874
+26% +$234K
SJM icon
321
J.M. Smucker
SJM
$12.7B
$1.1M 0.02%
8,573
+3,262
+61% +$435K
FOLD
322
DELISTED
Amicus Therapeutics
FOLD
$1.09M 0.02%
+101,911
New +$839K
MCHP icon
323
Microchip Technology
MCHP
$40.4B
$1.09M 0.02%
18,825
+1,903
+11% +$126K
VTWO icon
324
Vanguard Russell 2000 ETF
VTWO
$17.7B
$1.08M 0.02%
15,826
-2,478
-14% -$184K
SYK icon
325
Stryker
SYK
$129B
$1.08M 0.02%
5,426
-715
-12% -$168K

Similar funds

Pathstone Family Office's Q2 2022 Portfolio in Review

As of Q2 2022, Pathstone Family Office held 1,175 positions worth $4.54B, up 5.9% from $4.29B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pathstone Family Office deployed $1.18B of net new capital in Q2 2022, opening 218 new positions and adding to 613 existing holdings. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 3,460,856 shares worth $74.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Elevance Health, an estimated $140M trimmed.

  • Pathstone Family Office's largest Q2 2022 buy was Dimensional World ex US Core Equity 2 ETF: 3,460,856 shares worth $74.2M.
  • Pathstone Family Office added most to Coca-Cola in Q2 2022, an estimated $172M increase.
  • Pathstone Family Office's biggest Q2 2022 reduction was Elevance Health, cutting an estimated $140M.
  • Pathstone Family Office fully exited Schwab US REIT ETF in Q2 2022, selling an estimated $4.41M.
  • Pathstone Family Office's ten largest holdings make up 34% of its $4.54B portfolio in Q2 2022.
  • Pathstone Family Office opened 218 new positions and closed 126 in Q2 2022.
  • Pathstone Family Office's portfolio value rose 5.9% quarter-over-quarter to $4.54B.

Based on Pathstone Family Office's 13F filing for Q2 2022, filed 15 Aug 2022.